Related Experiment Video
Updated: Oct 23, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Breast Reconstruction in a Coronavirus Disease 2019 Hub
Andrea Lisa1, Andrea Battistini1, Silvia Giannasi1
1Plastic Surgery Unit, Department of Medical Biotechnology and Translational Medicine BIOMETRA, Humanitas Clinical and Research Hospital, Reconstructive and Aesthetic Plastic Surgery School, University of Milan, Rozzano, Milan, Italy.
Insights
During the COVID-19 pandemic, a new protocol for immediate implant-based breast reconstruction was safely and effectively implemented for cancer patients, showing no increase in complications or pain.
Area of Science:
- Oncology
- Plastic Surgery
- Infectious Disease Epidemiology
Background:
- The COVID-19 pandemic significantly disrupted healthcare systems globally.
- Humanitas Clinical and Research Hospital became a regional hub for COVID-19 patient care.
- This necessitated adaptations in surgical protocols, particularly for cancer patients.
Purpose of the Study:
- To evaluate the safety and efficacy of a new protocol for immediate implant-based breast reconstruction during the COVID-19 pandemic.
- To assess the feasibility of performing oncologic surgery and reconstruction while minimizing risks.
- To adapt surgical practices in a high-risk environment.
Main Methods:
- A new protocol was adopted for breast cancer patients undergoing mastectomy and immediate reconstruction.
- Key goals included reducing COVID-19 transmission risk, prioritizing oncologic surgery, and enabling rapid patient discharge.
- Pain management strategies and reduced postoperative consultations were integral to the protocol.
Main Results:
- The protocol was applied to 51 patients in the first month of the pandemic (March-April 2020).
- A retrospective review found no significant increase in postoperative pain or complication rates compared to pre-pandemic data.
- The protocol facilitated timely oncologic treatment and reconstruction.
Conclusions:
- The developed protocol is safe and effective for immediate implant-based breast reconstruction in cancer patients.
- It allows for successful tumor resection and reconstruction without compromising patient or staff safety.
- This approach demonstrates adaptability in surgical care during a pandemic.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic presented a dramatic challenge to healthcare systems. Humanitas Clinical and Research Hospital (Rozzano, MI, Italy) was declared a regional hub for the treatment of COVID-19 patients. Our plastic surgery team, in consultation with our breast surgery colleagues, decided to perform immediate implant-based breast reconstruction for patients undergoing mastectomy for cancer. In this report, we present our experience performing breast reconstruction with a new protocol in the first month following the COVID-19 pandemic in the most affected region in Italy.
Methods:
We adopted a new protocol to treat patients with breast cancer during the COVID-19 pandemic. The main goals of our protocol were to reduce the risk of COVID-19 spread for both patients and clinicians, postpone nononcologic and more advanced surgery, develop rapid recovery for early patient discharge (within 24 hours from surgery) through pain management, and finally reduce postoperative consultations.
Results:
The protocol was applied to 51 patients between early March and early April 2020. After 1 month, we decided to retrospectively review our experience. We found no significant differences in terms of postoperative pain and complication rate compared with our data in the pre-COVID period.
Conclusion:
Our new protocol is safe and effective, enabling tumor resection and immediate implant-based breast reconstruction, without increasing risks to the patient or staff.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025